TREM2 and Alzheimer disease: The regulatory function of TREM2 could be confirmed by comparing microglia differentiated from wild-type and isogenic TREM2 knockout human iPSCs, suggesting that these cells can be applied to study AD related disease settings (Reich et al., 2021).